Olema Oncology

Olema Oncology

Director, Clinical Science

San Francisco, California · Director

Sponsorship not specified$220k-$245kDetected 7 days ago
GCPPharmacologyFDA RegulatoryCommunicationCollaborationPublic SpeakingAdaptabilityBiostatistics

About the role

  • Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond.
  • OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients.
  • Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape - particularly in combination with palazestrant.

Responsibilities

  • Writing of technical and clinical documents including protocols, amendments, investigator's brochures, and the clinical sections of regulatory documents
  • Interacting with investigators and thought leaders in oncology to facilitate the design of clinical synopses and protocols
  • Organizing and performing the study level and individual subject level analysis of the clinical trial data to gain insights and develop strategies for the clinical study report (CSR) writing
  • Collaborating with Clinical Operations and other internal study teams to develop Informed Consent Forms, Case Report Forms and CRF instructions

Nice to have

  • Advanced degree such as a PhD or PharmD is strongly preferred
  • Experience in oncology clinical development is required
  • Comprehensive knowledge of oncology clinical trial implementation and drug development process
  • Demonstrated understanding of the clinical drug development process to execute drug development strategic plans and meet milestones
  • A minimum of 8 years' experience in biotech/pharmaceutical industry is required
  • Strong knowledge of Good Clinical Practices (GCP), FDA, and EMEA/CHMP regulations and guidelines
  • familiarity with other international regulatory requirements is a plus
  • Proactively identifying challenges/problems and proposing solutions with a strong sense of urgency

Compensation

  • The base pay range for this position is expected to be $220,000 - $245,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience.

Benefits

  • Evaluate the safety, pharmacology, and efficacy of ongoing studies in close collaboration with the medical monitor and the safety, pharmacology and clinical operations teams
  • Collaborating with the Medical Monitor on review of enrollment packets, clinical development plans and scientific presentations

Company info

  • We are aware of employment scams where individuals pose as representatives of Olema Oncology and make false use of our company name to defraud job seekers.
  • To protect yourself, please note that Olema's official email addresses end in @olema.com.
  • Our official corporate website is olema.com; our careers page is olema.com/careers; our LinkedIn page is <a class="x_Hyperlink x

This listing is sourced directly from Olema Oncology's careers page and normalized into a canonical job model.